Cellectar Biosciences
Cellectar Biosciences, Inc. - Common Stock recently split on Friday, July 22, 2022 with a ratio of 1:10
Last update: 9:30AM
Day High/Low5.54 - 5.58
52 Week High/Low0.34 - 6.76
Open / Close5.58 / -
Float / Outstanding6.1M / 6.1M
Vol / Avg.0.7K / 108.7K
Mkt Cap33.9M
50d Avg. Price2.31
Div / Yield-
Payout Ratio-
Total Float6.1M

Cellectar Biosciences (NASDAQ:CLRB), Earnings Estimates, EPS, and Revenue

Cellectar Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Aug 5



Quarterly Revenue


Annual Revenue (as of Jun 30)

Earnings Recap

Cellectar Biosciences (NASDAQ:CLRB) reported its Q2 earnings results on Friday, August 5, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.


Cellectar Biosciences missed estimated earnings by 18.45%, reporting an EPS of $-1.22 versus an estimate of $-1.03.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 2.94% drop in the share price the next day.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings History

Analyze the earnings history of Cellectar Biosciences using advanced sorting and filters.

Prior EPS
Actual EPS
EPS Surprise
Prior Rev
Est Rev
Actual Rev
Rev Surprise
Get Alert

Cellectar Biosciences Questions & Answers

When is Cellectar Biosciences (NASDAQ:CLRB) reporting earnings?

Cellectar Biosciences (CLRB) is scheduled to report earnings on November 7, 2022. The last reported earnings were for reported on August 5, 2022 for Q2.

What were the latest earnings per share (EPS) for Cellectar Biosciences (NASDAQ:CLRB)?

The Actual EPS was $-16.00, which beat the estimate of $-25.00.

What were Cellectar Biosciences’s (NASDAQ:CLRB) revenues?

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.